Article 3418

Title of the article



Zamotaeva Mariya Nikolaevna, Candidate of medical sciences, associate professor, sub-department of pharmacology and clinical pharmacology with a course pharmaceutical technology, National Research Ogarev Mordovia State University (68 Bolshevistskaya street, Saransk, Russia), E-mail:
Konorev Vladimir Vladimirovich, Postgraduate student, National Research Ogarev Mordovia State University (68 Bolshevistskaya street, Saransk, Russia), E-mail:
Zaytseva Elizaveta Nikolaevna, Student, National Research Ogarev Mordovia State University (68 Bolshevistskaya street, Saransk, Russia), E-mail:
Semenov Aleksandr Vladimirovich, Candidate of chemical sciences, associate professor, sub-department of organic chemistry, National Research Ogarev Mordovia State University (68 Bolshevistskaya street, Saransk, Russia), E-mail:
Kuznetsov Yuriy Vasil'evich, Candidate of chemical sciences, senior staff scientist, Laboratory of Antioxidant Chemistry, N. M. Emanuel Institute of Biochemical Physics RAS (4 Kosygina street, Moscow, Russia), E-mail: 

Index UDK





The impact of some derivative 3-oxypyridin (3-oxypyridin of succinate, 3-oxypyridin of acetylcysteine, 3-oxypyridin of fumarate, 3-oxypyridin of adipate ester, 3-oxypyridin of hemisuccinate in dose strength 5% from LD50) on the rats learnin ability under the experimental chronic heart insufficiency (oleic sample) in the methodology for conditioned reflex with positive reinforcement (T-maze) was examined. 
The most effective reducing of latency time was identified on the test on preservation of acquired skill in the animals group, using 3-oxypyridin of hemisuccinate in dose strength 22 mg/kg, which suggests positive influence on learning ability and declines in level of anxiety. The reaction time decreased reliably in the group, using 3-oxypyridin of adipate ester in dose strength 40 mg/kg that suggests rats’ memory improving, in other words, consolidation of memorable footprint can occur under the influence of this substance. 

Key words

antioxidants, 3-oxypyridin, T-maze, nootropic activity 

Download PDF

1. Elias M. F., Sillivan L. M., Elias P. K. et al. J Stroke Cerebrovasc Dis. 2006, vol. 15, pp. 214–222.
2. Pressler S. J., Subramanian U., Kareken D. et al. Heart Failure. Nurs Res. 2010, № 59 (2), pp. 127–139.
3. Smirnova I. N., Fedorova T. N., Tanashyan M. M., Suslina Z. A. Atmosfera. Nervnye bolezni [ ]. 2006, no. 1, pp. 33–36.
4. Gashilova F. F. Byulleten' eksperimental'noy biologii i meditsiny [Bulletin of experimental biology and medicine]. 2012, app. 1, pp. 18–22.
5. Drozdova T. V., Fit'mova O. A., Fit'mova A. A. Farmateka [Pharmacy]. 2012, no. 14 (247), pp. 97–103.
6. Zamotaeva M. N., Inchina V. I., Konorev V. V., Kuznetsov Yu. V., Kuz'michev N. D. Byulleten' eksperimental'noy biologii i meditsiny [Bulletin of experimental biology and medicine]. 2018, vol. 165, no. 3, pp. 317–320.
7. Rumyantseva T. A., Fateev M. M., Fedorov V. N., Sal'nikov E. V., Sidorov A. V. Vestnik Nizhegorodskogo universiteta im. N. I. Lobachevskogo [Bulletin of Lobachevsky State University of Nizhny Novgorod]. 2009, no. 5, pp. 123–127.
8. Rukovodstvo po eksperimental'nomu (doklinicheskomu) izucheniyu novykh farmakologicheskikh veshchestv [Guidance on the experimental (preclinical) study of new pharmaceutical substances]. Ed. by prof. R. U. Khabriev. 2nd ed. rev. and updated. Moscow: Meditsina, 2005, 832 p.


Дата создания: 17.06.2019 13:26
Дата обновления: 17.06.2019 14:01